First Citizens Bank & Trust’s Myriad Genetics MYGN Stock Holding History

First Citizens Bank & Trust’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-34,231	Closed	-$1.32M	–	346
2014 Q3	$1.32M	Buy	34,231 +1,093	+3%	+$40.8K	0.11%	135
2014 Q2	$1.29M	Sell	33,138 -24	-0.1%	-$893	0.11%	138
2014 Q1	$1.13M	Sell	33,162 -1,968	-6%	-$61K	0.1%	141
2013 Q4	$737K	Sell	35,130 -8,019	-19%	-$203K	0.07%	192
2013 Q3	$1.01M	Sell	43,149 -2,269	-5%	-$64.5K	0.04%	412
2013 Q2	$1.22M	Buy	+45,418	New	+$1.32M	0.05%	339

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Citizens Bank & Trust's MYGN Position: Q4 2014 in Review

First Citizens Bank & Trust sold out of Myriad Genetics (MYGN) in Q4 2014, closing a stake of 34,231 shares — an estimated $1.32M sold.

First Citizens Bank & Trust first reported a position in MYGN in Q2 2013 and held it in 6 quarters. The position peaked at $1.32M in Q3 2014. 272 funds tracked by Wall St. Rank hold MYGN as of Q4 2014.

First Citizens Bank & Trust reported no remaining Myriad Genetics position as of Q4 2014 after selling out during the quarter.
First Citizens Bank & Trust sold 34,231 Myriad Genetics shares in Q4 2014, an estimated $1.32M.
First Citizens Bank & Trust first reported a position in Myriad Genetics in Q2 2013 and held it in 6 quarters.
First Citizens Bank & Trust's Myriad Genetics position peaked at $1.32M in Q3 2014.
272 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2014.

Based on First Citizens Bank & Trust's 13F filing for Q4 2014, filed 27 Jan 2015.